Age-Related Macular Degeneration Market Competitive Landscape, Growth Factors, Revenue Analysis Till 2027

 


The growing awareness of AMD and the increasing geriatric population are anticipated to exhibit more opportunities for the growth of the age-related macular degeneration market. Moreover, as per the Community Eye Health Journal published in 2014 by the London School of Hygiene and Tropical Medicine, nearly 196 million people are estimated to suffer from age-related macular degeneration by 2020 worldwide.

The global market for age-related macular degenerations is expected to grow at a CAGR of approximately 7.3% during the forecast period.

Regionally, the Americas age-related macular degeneration market is segmented into two major regions, namely, North America and South America.

Treatments targeting biochemical pathways implicated in the macular degeneration pathophysiology of ARMD are being tested actively in clinical trials

The Americas region holds the largest share of the global age-related macular degeneration market owing to the increasing cases of macular degeneration and growing health concerns. According to the Centers for Disease Control and Prevention (CDC), it was estimated that about 1.8 million people are suffering from age-related macular degenerations in America. Moreover, nearly 7.3 million people are at a significant risk of vision loss due to AMD.

The global age-related macular degeneration market is segmented by type, drug, route of administration, treatment, and end-user.

On the basis of type, the global age-related macular degeneration market is segmented into dry age-related macular degeneration and wet age-related macular degeneration.

On the basis of drug, the global age-related macular degeneration market is segmented into Eylea, Visudyne, Lucentis, Avastin, and others.

On the basis of route of administration, the global age-related macular degeneration market is segmented into intravenous, intravitreal, and others.

On the basis of treatment, the global age-related macular degeneration market is segmented into medications, devices, surgery, and others. The medication segment is further classified into anti-VEGF drugs, blood vessel growth inhibitors, vitamins, dietary supplements, and others. The devices segment is classified into corrective lenses, glasses, contact lenses, and others.

On the basis of end-user, the global age-related macular degeneration market is segmented into hospitals and diagnostic centers, clinics, academic research institutes, pharmaceutical and biotechnology companies, and others.

Some of the key players in the global age-related macular degeneration market are Novartis International AG (Switzerland), Bayer AG (Germany), Acucela Inc. (U.S.), Neurotech Pharmaceuticals Inc. (U.S.), Ophthotech Corporation (U.S.), GlaxoSmithKline Plc (U.S.), Alimera sciences Inc. (U.S.), StemCell Inc. (Canada), F. Hoffmann-La Roche Ltd. (Switzerland), Regeneron Pharmaceutical Inc. (U.S.), Allergan Plc (Ireland), Adverum Biotechnologies Inc. (U.S.), Gilead Sciences Inc. (U.S.), Iconic Therapeutics Inc. (U.S.), Lpath Inc. (U.S.), OHR Pharmaceutical Inc. (U.S.), Bausch + Lomb (U.S.), Opthea Limited (Canada), PanOptica, Inc. (U.S.), Pfizer Inc. (U.S.), Neurotech Pharmaceuticals, Inc. (U.S.), Promedior, Inc. (U.S.), QLT Inc. (Canada), Quark (U.S.), Resolvyx Pharmaceuticals Inc. (U.S.), RXi Pharmaceuticals Inc. (U.S.), Sagent Pharmaceuticals, Inc. (U.S.), Alcon Vision Care (U.S.), Santen Pharmaceutical Co., Ltd. (Japan), Sanwa Kagaku Kenkyusho (Japan), and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com


Comments

Post a Comment

Popular posts from this blog

ICP-OES Spectrometer Industry Size, Share, Key Players, Growth Trend, and Forecast Till 2030

Image
  The global  ICP-OES Spectrometer Industry  was valued at USD 521.4 million in 2018 at a CAGR of 7.2% during the forecast period of 2019 to 2025. ICP-OES Spectrometer is an analytical instrument that is used for the detection of chemical elements. It uses the technique of inductively coupled plasma optical emission spectroscopy (ICP-OES) for carrying out its analysis procedure. Certain factors that propel the growth of the ICP-OES Spectrometer Industry include increasing R&D expenditure for the development of better analytical systems and growing technological advancements. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8120 However, the high cost of instruments and requirement of large capital investment for setting up instrument manufacturing plants is hindering the growth of the global ICP-OES Spectrometer Industry in the forecast period. Currently, the global ICP-OES Spectrometer Industry is dominated by several players. ...
Read more

Opioid Withdrawal Treatment Market Growth, Size Analysis, DROT, PEST, Porter’s, Region & Country Forecast Till 2030

Image
The global  opioid withdrawal treatment growth market held a market value of USD 1.8 billion in 2018 and is projected to grow at a CAGR of 10.1% over the forecast period. Opioids are drugs such as heroin, opium, morphine, codeine, and methadone that are used in cases of severe, postsurgical, or chronic pain. In some cases, usage of opioids causes addiction, and Opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. These drugs can also cause severe health problems and sometimes even result in overdose and loss of life. Hence this opioid dependence requires treatment, which is known as opioids withdrawal treatment. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8123 Segmentation The global opioid withdrawal treatment market has been segmented into drug type and distribution channel. By drug type, the market has been segmented into the nonsteroidal anti-inflammatory drugs, anti-nausea medications, a...
Read more

Preclinical Imaging Market Trends, Size, Key Factors, Major Players, Growth Strategies, Forecast Till 2027

Image
Preclinical Imaging Market Trends , Revenue Forecast, Competitive Landscape, Growth Factors, and Research Report: by Product (Optical Imaging, Nuclear Imaging, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging System), by Reagent (Optical, Nuclear, CT Contrast Agents, MRI Contrast Agents) The global preclinical imaging anticipated to have held a market value of USD 2.01 billion in the year 2017 and is expected to grow at a CAGR of 6.3% during the forecast period. Preclinical imaging solutions are used during the preclinical research for visualization of living animals. It is playing important role during drug development process. It is evaluating the effectiveness and safety of new treatments and describing drug distribution patterns before clinical use. preclinical imaging solutions has broad application field such as, neurology; cardiology; inflammation; infectious diseases; cancer research; functional and anatomical neuroimaging, orthopedics; and cardiac imaging. Requ...
Read more